Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended				6 Months Ended		8 Months Ended	9 Months Ended		12 Months Ended
	Sep. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net income (loss)	$ (80,411,000)	$ (118,031,000)	$ 14,311,000	$ (24,940,000)	$ (101,376,000)	$ (7,148,000)		$ (181,787,000)	$ 7,163,000	$ 10,140,000	$ (7,617,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation								1,319,000	944,000
Bad debt expense (recovery)								440,000	(836,000)
Impairment of property and equipment (see Note 4)	5,044,000		0					5,044,000	0
Share-based compensation expense								7,180,000	2,748,000
Change in fair value of SAFE Agreements	0		0					0	2,353,000
Change in fair value of earn-out liabilities	33,328,000		(36,036,000)					33,816,000	(61,066,000)
Change in fair value of warrant liabilities	33,686,000		(10,259,000)					36,641,000	(10,259,000)
Loss on issuance of securities	0		6,729,000					68,080,000	6,729,000
Other								108,000	25,000
Changes in operating assets and liabilities:
Trade accounts receivable, net								(34,871,000)	(314,000)
Contract assets								(15,083,000)	4,974,000
Prepaid expenses								(55,000)	(1,471,000)
Other assets, net								852,000	539,000
Accounts payable and accrued expenses								2,194,000	6,995,000
Accounts payable – affiliated companies								238,000	1,568,000
Contract liabilities – current and long-term								14,314,000	(6,285,000)
Other liabilities								5,948,000	23,260,000
Net cash used in operating activities								(55,622,000)	(22,933,000)
Cash flows from investing activities:
Purchase of property and equipment								(5,185,000)	(27,668,000)
Net cash used in investing activities								(5,185,000)	(27,668,000)
Cash flows from financing activities:
Proceeds from Business Combination								0	8,055,000
Proceeds from issuance of Series A Preferred Stock								0	26,000,000
Transaction costs								(437,000)	(9,371,000)
Proceeds from borrowings								10,000,000	0
Repayment of loans								(18,000,000)	0
Proceeds from issuance of securities								107,935,000	20,000,000
Member distributions								0	(7,952,000)
Stock option exercises								300,000	0
Payment of withholding taxes from share-based awards								(2,291,000)	(293,000)
Forward purchase agreement termination								0	12,730,000
Warrants exercised								51,360,000	16,124,000
Contributions from (distributions to) noncontrolling interests								(973,000)	196,000
Net cash provided by financing activities								147,894,000	65,489,000
Net increase in cash, cash equivalents and restricted cash								87,087,000	14,888,000
Cash, cash equivalents and restricted cash at beginning of the period		$ 4,560,000		$ 25,826,000	$ 4,560,000	$ 25,826,000		4,560,000	25,826,000	25,826,000
Cash, cash equivalents and restricted cash at end of the period	91,647,000		40,714,000				$ 40,714,000	91,647,000	40,714,000	4,560,000	$ 25,826,000
Less: restricted cash	2,042,000		62,000				62,000	2,042,000	62,000
Cash and cash equivalents	89,605,000		40,652,000				40,652,000	89,605,000	40,652,000	$ 4,498,000
Supplemental disclosure of cash flow information
Cash paid for interest, net								408,000	1,423,000
Cash paid for taxes								277,000	36,000
Accrued capital expenditures								0	579,000
Right-of-use assets obtained in exchange for new operating lease liabilities								4,264,000	0
Noncash financing activities:
Transaction costs	$ 0		$ 15,074,000				15,074,000	0	15,074,000
SAFE Agreements								0	20,667,000
Class A Common Stock related to Equity Facility (Note 7)							19,376,000
Conversion of Series A preferred stock (Note 7)								23,120,000	0
Preferred dividends								(751,000)	(1,657,000)
Commitment Shares
Noncash financing activities:
Class A Common Stock related to Equity Facility (Note 7)							$ 834,000	$ 0	$ 834,000